2026-10-28 12:30:00 UTC#528627newconfirmednews
ExpreS2ion Biotech Holding AB stock news
ExpreS2ion Biotech Holding AB stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire10 wire items
2026-10-23 08:30:00 UTC#505187newconfirmednews
ExpreS2ion Biotech completes enrollment for ES2B-C001 breast cancer trial; primary readout delayed to Q1 2027
2026-10-05 17:00:00 UTC#414945newconfirmednews
ExpreS2ion Biotech raises SEK 19.3M via directed share issue at SEK 1.60, causing 39.8% dilution
tradingviewimportance 0.50trust 0.70ExpreS2ion Biotech Holding AB -0.50Vator Securities -0.10ES2B-C001 +0.20
2026-10-01 08:30:00 UTC#397065newconfirmednews
ExpreS2ion Biotech Holding AB (EXPRS2) EGM authorizes board to issue equity and convertible securities
2026-09-23 14:51:12 UTC#356412newconfirmednews
ExpreS2ion Biotech to raise SEK 19.3 million via warrants and share issue
2026-09-23 14:50:00 UTC#356422duplicateconfirmednews
ExpreS2ion Biotech to raise SEK 19.3M via 1.1% TO 13 exercise and directed share issue
2026-09-14 20:05:00 UTC#309818newconfirmednews
ExpreS2ion Biotech Secures SEK 19.3M TO 13 Warrant Guarantee and SEK 50M Put Option Facility
2026-08-20 07:43:01 UTC#199357duplicateconfirmednews
ExpreS2ion Biotech Q2 2026 results highlight ES2B-C001 clinical progress and SEK 32.4M rights issue
2026-08-20 06:41:09 UTC#199168duplicateconfirmednews
ExpreS2ion Biotech Holding AB Reports Q2 2026 Operating Income of SEK 11.5 Million and Loss of SEK 9.7 Million
2026-08-20 06:35:22 UTC#199143newconfirmednews